GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-2126 |
Esophagus - mucosa
|
PAXgene |
1
|
6 pieces; well preserved & well dissected mucosa with <5% submucosal glands
|
Acceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-2226 |
Esophagus - muscularis
|
PAXgene |
1
|
6 pieces; well dissected muscularis
|
Acceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-2326 |
Mammary tissue (breast)
|
PAXgene |
1
|
2 pieces; fibrocystic changes with intraductal hyperplasia
|
Acceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-2426 |
Gastroesophageal junction
|
PAXgene |
1
|
6 pieces; well dissected muscularis
|
Acceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-2526 |
Pancreas
|
PAXgene |
3
|
2 pieces; exocrine and endocrine elements affected by autolysis
|
Acceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-2626 |
Stomach
|
PAXgene |
2
|
6 pieces; 4 have full thickness mucosa & muscularis; 1 has mucosa only, 1 has muscularis only; mucosa severely autolyzed superficially, slightly autolyzed deeply
|
Acceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-2726 |
Kidney - cortex
|
PAXgene |
2
|
6 pieces; arteriolar, arterial & glomerular sclerosis; tubules severely autolyzed; medulla sampled as well as cortex
|
Unacceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-2826 |
Omentum
|
PAXgene |
1
|
2 pieces; 5% lymphoid content; <5% fibrovascular content
|
Acceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-2926 |
Skin, suprapubic
|
PAXgene |
1
|
6 pieces; well trimmed; almost hair free; <5% dermal fat
|
Acceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-3026 |
Brain - cortex
|
PAXgene |
1
|
4 pieces; well dissected; small amount of leptomeninges in sulci
|
Acceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-3126 |
Pituitary gland
|
PAXgene |
1
|
1 piece; posterior lobe outlined [30% of total]
|
Acceptable
|
|
GTEX-1RDX4
|
51-60
|
Female
|
GTEX-1RDX4-3226 |
Brain - cerebellum
|
PAXgene |
1
|
4 pieces; well dissected
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-0126 |
Skin, leg
|
PAXgene |
1
|
6 pieces; 10% to 30% external fat (outlined); insignificant periadnexal fat; ~37 microns thick epidermis
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-0226 |
Adipose tissue
|
PAXgene |
1
|
2 pieces; mature adipose tissue and fibrovascular component
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-0326 |
Artery - tibial
|
PAXgene |
1
|
2 pieces; cross sections of vessels with attached adventitia and trace of external fat
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-0426 |
Nerve - tibial
|
PAXgene |
1
|
2 pieces; nerves with prineurium and trace of external fat
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-0526 |
Muscle, skeletal
|
PAXgene |
1
|
2 pieces; one is fragmented
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-0626 |
Mammary tissue (breast)
|
PAXgene |
1
|
2 pieces; fibroadipose tissue with mammary lobules (outlined) and duct (arrow)
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-0726 |
Aorta
|
PAXgene |
1
|
6 pieces; up to ~0.7mm attached adventitia
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-0826 |
Omentum
|
PAXgene |
1
|
2 pieces; lobulated mature adipose tissue with
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-0926 |
Lung
|
PAXgene |
1
|
2 pieces; massive pneumonia; marked congestion
|
Unacceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-1026 |
Spleen
|
PAXgene |
1
|
2 pieces; marked congestion
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-1126 |
Esophagus - muscularis
|
PAXgene |
1
|
6 pieces; target muscularis; 3 pieces with squamous epithelium (arrows), submucosa and submucosal glands (outlined)
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-1226 |
Esophagus - mucosa
|
PAXgene |
1
|
6 pieces; ~160 microns thick stratified squamous epithelium; submucosal glands with ducts (outlined)
|
Acceptable
|
|
GTEX-1RNTQ
|
21-40
|
Female
|
GTEX-1RNTQ-1326 |
Gastroesophageal junction
|
PAXgene |
1
|
6 pieces; target muscularis not well represented; stratified squamous epithelium, submucosa, submucosal glands and focal submucosal lymphocytic infiltration
|
Unacceptable
|
|